The impaired bone metabolism in TIO is due to FGF23-induced hypophosphatemia resulting from renal phosphate wasting as well as decreased intestinal phosphate absorption through decreased 1,25-dihydroxy vitamin D production. This evidence concerns the gene FGF23 and hypophosphatemia.